EUVIMEDEUVIMED entdecken
Crossref

Microbiota encroachment and a gut-adipose-liver axis in metabolic dysfunction-associated steatotic liver disease

Daria Igudesman iD, GongXin Yu, Charlene Dauriat, Torfay Roman, Maryam R Kashi, Elizabeth Blakley, Benoit Chassaing iD, Karen D Corbin iD

American Journal of Physiology-Gastrointestinal and Liver Physiology · 2025

DOI: 10.1152/ajpgi.00381.2024 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Physiology-Gastrointestinal and Liver Physiology, 2025. Verfasst von Daria Igudesman und 7 weiteren Autor:innen. Beteiligte Einrichtung: AdventHealth Translational Research Institute, Orlando, Florida, United States. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Liver, Fatty Liver, Adipose Tissue. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 93 Literaturangaben. Gefördert von: Merck (Merck & Co.), EC | ERC | HORIZON EUROPE European Research Council (ERC), Agence Nationale de la Recherche (ANR).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In a first-in-human study, we observed that colonic expression of insulin and lipid-related genes may bridge the pathophysiology of colonic microbiota encroachment with adipose tissue insulin resistance and metabolic dysfunction-associated steatotic liver disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal MicrobiomeLiverFatty LiverAdipose TissueColonNon-alcoholic Fatty Liver DiseaseHumansMaleFemaleMiddle AgedInsulin ResistanceAgedAdult

Stichwörter der Autor:innen

gut microbiotahepatic fibrosishepatic steatosisintestinal permeabilitymicrobiota encroachment

Autor:innen und Institutionen

  • AdventHealth Translational Research Institute, Orlando, Florida, United States.
  • Microbiome-Host Interactions, Institut Pasteur, Université Paris Cité, INSERM U1306, Paris, France.
  • AdventHealth Transplant Institute, AdventHealth Medical Group, Orlando, Florida, United States.
  • Department of Gastroenterology, AdventHealth Medical Group, Orlando, Florida, United States.

ORCID-Profile: Daria Igudesman, Benoit Chassaing, Karen D Corbin

Förderung

  • Merck (Merck & Co.)
  • EC | ERC | HORIZON EUROPE European Research Council (ERC)
  • Agence Nationale de la Recherche (ANR)

Zitieren

APA

Igudesman, D., Yu, G., Dauriat, C., Roman, T., Kashi, M. R., Blakley, E., Chassaing, B., & Corbin, K. D. (2025). Microbiota encroachment and a gut-adipose-liver axis in metabolic dysfunction-associated steatotic liver disease. American Journal of Physiology-Gastrointestinal and Liver Physiology. https://doi.org/10.1152/ajpgi.00381.2024

Vancouver

Igudesman D, Yu G, Dauriat C, Roman T, Kashi MR, Blakley E, et al. Microbiota encroachment and a gut-adipose-liver axis in metabolic dysfunction-associated steatotic liver disease. American Journal of Physiology-Gastrointestinal and Liver Physiology. 2025. doi:10.1152/ajpgi.00381.2024

BibTeX
@article{Igudesman2025,
  author = {Igudesman, Daria and Yu, GongXin and Dauriat, Charlene and Roman, Torfay and Kashi, Maryam R and Blakley, Elizabeth and Chassaing, Benoit and Corbin, Karen D},
  title = {Microbiota encroachment and a gut-adipose-liver axis in metabolic dysfunction-associated steatotic liver disease},
  journal = {American Journal of Physiology-Gastrointestinal and Liver Physiology},
  year = {2025},
  doi = {10.1152/ajpgi.00381.2024}
}
Kostenlos starten →